150 related articles for article (PubMed ID: 151715)
21. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
Kubota E; Ishikawa H; Saito K
J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
[TBL] [Abstract][Full Text] [Related]
22. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
23. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
Ishikawa H; Kubota E; Saito K
J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
[TBL] [Abstract][Full Text] [Related]
24. Impairment of graft versus host reactivity in pregnant mice.
Nicklin S; Billington WD
Clin Exp Immunol; 1982 Jul; 49(1):135-41. PubMed ID: 7127896
[TBL] [Abstract][Full Text] [Related]
25. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
Kosmatopoulos K; Algara DS; Orbach-Arbouys S
J Immunol; 1987 Feb; 138(4):1038-41. PubMed ID: 3492538
[TBL] [Abstract][Full Text] [Related]
26. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
Bear HD
Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
[TBL] [Abstract][Full Text] [Related]
27. Immunosuppressive effect of pregnant mouse serum on allostimulatory activity of dendritic cells.
Shojaeian J; Moazzeni SM; Nikoo S; Bozorgmehr M; Nikougoftar M; Zarnani AH
J Reprod Immunol; 2007 Aug; 75(1):23-31. PubMed ID: 17434209
[TBL] [Abstract][Full Text] [Related]
28. Suppression of antigraft immunity by preimmunization. III. Characterization of suppressor T cells involved in suppression of the efferent phase of DTH against alloantigens.
Bianchi AT; Hussaarts-Odijk LM; Wolters EA; Molendijk A; Benner R
J Immunol; 1986 Jul; 137(2):433-42. PubMed ID: 2941481
[TBL] [Abstract][Full Text] [Related]
29. Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1.
Tuttle TM; Inge TH; Bethke KP; McCrady CW; Pettit GR; Bear HD
Cancer Res; 1992 Feb; 52(3):548-53. PubMed ID: 1732041
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic cell populations in normal and alloimmunized pregnant mice.
Smith G; Chappell F
Immunology; 1984 May; 52(1):49-54. PubMed ID: 6715021
[TBL] [Abstract][Full Text] [Related]
31. Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow.
Sado T; Kamisaku H; Kubo E
J Immunol; 1985 Feb; 134(2):704-10. PubMed ID: 3880789
[TBL] [Abstract][Full Text] [Related]
32. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
[TBL] [Abstract][Full Text] [Related]
33. Altered host-allograft relationships for mouse tumors modified by prior passage in vitro and in vivo. II. Reactivity of lymphoid cells.
Jacobs BB
J Natl Cancer Inst; 1972 Oct; 49(4):1085-91. PubMed ID: 4404346
[No Abstract] [Full Text] [Related]
34. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
[TBL] [Abstract][Full Text] [Related]
35. T-reg mediated suppression of the allograft response in the draining lymph node.
Lee MK; Moore DJ; Chiaccio M; Lian MM; Deng S; Mohiuddin M; Huang X; Koeberlein B; Zakheim A; Porrett PM; Barker CF; Caton AJ; Markmann JF
Transplantation; 2006 Apr; 81(7):1063-6. PubMed ID: 16612285
[TBL] [Abstract][Full Text] [Related]
36. Impairment of host-versus-graft reaction in pregnant mice. II. Selective suppression of cytotoxic T-cell generation correlates with soluble suppressor activity and with successful allogeneic pregnancy.
Clark DA; McDermott MR; Szewczuk MR
Cell Immunol; 1980 Jun; 52(1):106-18. PubMed ID: 6446406
[No Abstract] [Full Text] [Related]
37. Spleen cell transplantation in mice: influence of non-H-2 M locus on graft-vs.-host and host-vs.-graft reactions.
Huber B; Peña-Martinez J; Festenstein H
Transplant Proc; 1973 Dec; 5(4):1373-5. PubMed ID: 4149546
[No Abstract] [Full Text] [Related]
38. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
[TBL] [Abstract][Full Text] [Related]
39. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the mechanism of allograft rejection and cell-mediated immunity. II. Divergent effect of CY pretreatment on the generation of cytotoxic activity in the draining lymph nodes and spleen.
Nanishi F; Taniguchi K; Kubo C; Onoyama K; Omae T; Nomoto K
J Clin Lab Immunol; 1983 Sep; 12(1):23-30. PubMed ID: 6631941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
